If you’ve been following skincare trends recently, you’ve probably noticed one ingredient appearing almost everywhere: PDRN.
From Korean skincare serums and moisturisers to luxury anti-ageing treatments, PDRN is being promoted as the next big ingredient for skin rejuvenation, hydration, firmness, and repair.
Some brands call it salmon DNA. Others describe it as a skin-regenerating ingredient that supports collagen production and helps damaged skin recover.
And with so many products making impressive claims, it’s easy to assume that PDRN is already a well-established cosmetic active.
But when we look at the scientific research, the story becomes much more interesting.
PDRN has been investigated for its potential role in tissue repair and regenerative medicine for years. More recently, researchers have begun exploring how it might work in topical skincare formulations.
However, an ingredient showing promising effects in laboratory experiments or injectable treatments doesn’t automatically mean it will produce the same results when added to a facial serum.
The real question isn’t simply whether PDRN works. It’s which form of PDRN is being used, how it’s delivered, and whether the evidence supports its performance in the finished product.
If you’re learning cosmetic formulation or developing skincare products professionally, understanding these differences is essential.
Let’s explore what PDRN actually is, what current research tells us, and the formulation challenges worth considering before incorporating it into cosmetic products.
What Is PDRN and Why Is It Used in Skincare?
PDRN stands for Polydeoxyribonucleotide.
It’s a material composed of fragments of DNA, which is the molecule responsible for carrying genetic information in living organisms.
Traditional pharmaceutical PDRN preparations contain purified DNA fragments, often with molecular weights ranging approximately from 50 to 1,500 kilodaltons (kDa).
These preparations have attracted scientific interest because of their potential effects on biological processes associated with tissue repair and inflammation.
Understanding the Origin of PDRN
Traditionally, PDRN has been produced using DNA extracted from the sperm cells of certain fish species, including rainbow trout and chum salmon.
The source material undergoes extraction and purification to obtain the DNA-derived fraction.
This explains why the ingredient is frequently described as salmon DNA in skincare marketing.
However, that description can be misleading if it suggests that finished skincare products contain unprocessed fish reproductive material.
Commercial PDRN ingredients are processed and purified raw materials.
And not every ingredient marketed as PDRN comes from the same source.
Newer materials include plant-derived DNA fragments and other DNA-based preparations.
Their properties can differ depending on the source, extraction process, purification method, and molecular weight distribution.
PDRN and Polynucleotides Are Related, but Not Always Identical
You may also have encountered another popular term in aesthetic medicine: polynucleotides, or PN.
Both PDRN and PN preparations consist of nucleic acid-based materials.
However, the terms are not always used consistently across scientific publications, commercial ingredient descriptions, and aesthetic treatments.
Some preparations differ in molecular weight distribution, concentration, physicochemical characteristics, and intended application.
This means a clinical study involving one polynucleotide preparation shouldn’t automatically be treated as evidence for every cosmetic ingredient marketed as PDRN.
For formulators, the precise identity of the material matters considerably more than the marketing terminology.
Understanding How PDRN May Work in the Skin
Before looking at clinical results, it’s useful to understand why researchers became interested in PDRN in the first place.
Much of the earlier research has focused on biological pathways associated with tissue repair.
Two mechanisms are frequently discussed: adenosine A2A receptor-related signalling and nucleotide salvage pathways.
Adenosine A2A Receptor Signalling
Adenosine is a naturally occurring molecule involved in several biological processes, including cellular signalling.
Adenosine A2A receptors participate in pathways associated with inflammation, blood vessel function, and tissue responses.
Experimental research suggests that some biological effects of PDRN preparations involve adenosine A2A receptor-related signalling.
This has encouraged research into potential effects on inflammatory responses, tissue repair, and the activity of certain skin cells.
However, an important distinction needs to be made.
Much of the mechanistic research has been conducted under controlled laboratory conditions or using PDRN administered through medical routes.
These findings don’t automatically establish that a conventional cosmetic serum applied to intact skin will activate the same pathways to a clinically meaningful degree.
Understanding the Nucleotide Salvage Pathway
Another proposed mechanism involves nucleotide salvage pathways.
Cells need nucleotides to synthesise and maintain nucleic acids.
Under certain conditions, recycled nucleotide components may contribute to cellular processes without requiring all nucleotides to be synthesised from the beginning.
PDRN-derived fragments and their breakdown products have therefore been investigated for their potential involvement in these pathways.
This provides an interesting biological explanation for some experimental findings.
But it shouldn’t be interpreted as proof that applying PDRN directly repairs damaged human DNA.
What Does the Scientific Evidence Actually Say About PDRN?
This is where separating the research becomes particularly important.
If you search for PDRN studies, you’ll find investigations involving wound healing, injectable treatments, post-procedure applications, laboratory cell models, and topical cosmetic products.
These are not equivalent forms of evidence.
The route of administration, treatment conditions, and specific material used can strongly influence the results.
The Evidence for PDRN in Wound Healing and Regenerative Medicine
PDRN was investigated in medical applications before becoming popular in everyday skincare.
Some clinical and preclinical studies have reported promising outcomes related to tissue repair and wound healing.
A systematic review published in July 2026 examined seven randomised trials involving 183 participants across polynucleotide and PDRN interventions.
The reviewed studies investigated skin rejuvenation, postoperative scar prevention, and wound healing.
The researchers found encouraging results, particularly in wound-healing applications.
However, they also highlighted important limitations, including small sample sizes, differences between treatment methods, and inconsistent outcome measurements.
The evidence was not sufficiently uniform to support definitive conclusions about the best treatment protocols.
This tells us that PDRN-related interventions have legitimate scientific interest, but further high-quality research is needed.
It also doesn’t establish that a commercially available PDRN facial serum will deliver the same outcomes.
The Evidence for Injectable PDRN and Polynucleotide Treatments
Injectable nucleotide-based treatments have attracted considerable attention in aesthetic dermatology.
They are commonly investigated for outcomes such as skin texture, elasticity, wrinkles, and overall skin appearance.
A systematic review published in the Journal of Cosmetic Dermatology in 2025 examined nine studies involving 219 patients receiving polynucleotide treatments.
The authors reported promising aesthetic outcomes but noted that the studies were generally of low or moderate quality.
There was also considerable variation in injection methods, treatment areas, and clinical protocols.
The researchers concluded that more rigorous studies were necessary.
For cosmetic formulators, there’s another important point.
Injectable products bypass much of the skin barrier.
A facial serum doesn’t.
This difference in delivery is one of the main reasons evidence from injectable treatments cannot simply be transferred to ordinary topical skincare.
The Evidence for Topical PDRN Is Beginning to Develop
For a long time, one of the biggest criticisms of topical PDRN was the lack of convincing human clinical evidence.
Much of the supporting research involved laboratory models or medical treatments.
However, newer studies published in 2025 and 2026 have begun investigating specific topical PDRN preparations.
These findings deserve attention, particularly because they offer a more nuanced picture than the assumption that topical PDRN cannot work at all.
A 2025 Study on Plant-Derived PDRN
A study published in the International Journal of Molecular Sciences investigated low-molecular-weight PDRN derived from Paeonia lactiflora, commonly known as peony.
Researchers evaluated its biological activity in laboratory models and conducted a small human study.
The topical formulation was associated with improvements in measurements of skin barrier recovery and periorbital elasticity.
The clinical investigation included a small number of participants, with approximately ten individuals per treatment group.
Although the findings were encouraging, the researchers acknowledged limitations, including the small sample size and short study duration.
The study is particularly interesting because it examined a plant-derived, low-molecular-weight DNA preparation.
However, these results cannot automatically be applied to conventional salmon-derived PDRN materials.
The source, molecular characteristics, and formulation system may be different.
A 2025 Study on Modified PDRN Delivery
Another study, published in 2025, investigated a modified PDRN material produced using plasma treatment.
The researchers aimed to influence the material’s surface charge and hydrodynamic size, potentially improving cellular uptake.
Laboratory results suggested improved uptake-related behaviour and cellular responses compared with the unmodified material.
The study also included a small human evaluation of a cosmetic cream containing the modified PDRN, reporting improvements in skin texture and radiance over two weeks.
These results are promising, but they don’t prove that conventional PDRN can produce identical effects.
The modification process was central to the research.
And short-term changes in skin texture or radiance don’t necessarily establish deeper biological regeneration.
A 2026 Study Comparing Topical PDRN With Retinol
One particularly interesting study was published in PLOS One in July 2026.
Researchers investigated a medium-length PDRN preparation described as PDRN-850K.
The study included laboratory experiments, skin penetration investigations, and a randomised, double-blind, split-face clinical study.
Thirty-one women were enrolled in the clinical study.
Participants applied an eye cream containing 0.1% PDRN-850K to one side of the face and a cream containing 0.1% retinol to the other side for 28 days.
The researchers reported improvements in several measurements associated with periocular wrinkles and skin characteristics.
The study also presented experimental evidence suggesting that this particular PDRN preparation could reach viable epidermal regions under the investigated conditions.
These findings are important because they challenge the idea that every form of topical PDRN is necessarily inactive.
But we still need to interpret them carefully.
The study was relatively short, evaluated a specific preparation and formulation, and used retinol rather than a peptide-free or PDRN-free vehicle as the principal clinical comparator.
The researchers also acknowledged limitations in distinguishing topical penetration signals and determining whether early improvements represented lasting structural changes rather than temporary hydration-related effects.
In addition, a four-week comparison with one retinol regimen cannot establish that PDRN is generally superior to retinoids.
The Skin Penetration Problem: PDRN’s Biggest Formulation Challenge
Now let’s look at one of the most important technical issues.
Even if a material has interesting biological activity, that activity may be difficult to reproduce in a topical cosmetic product if the material cannot reach an appropriate location within the skin.
Why Molecular Weight Matters
The outermost layer of the skin, the stratum corneum, forms an effective barrier against many external substances.
Larger molecules generally encounter greater difficulty crossing intact skin compared with smaller molecules having suitable physicochemical properties.
Traditional PDRN preparations contain relatively large DNA fragments.
These fragments are also highly hydrophilic and negatively charged.
Together, these characteristics can make passive skin penetration challenging.
This is one reason researchers have investigated changes in molecular weight distribution, chemical properties, and delivery systems.
Smaller DNA Fragments Don’t Automatically Mean Better Results
You might assume that the solution is simply to break PDRN into smaller fragments.
But reducing molecular size can also influence the material’s biological behaviour.
The size distribution of a DNA-derived ingredient may affect its physicochemical properties, stability, and potential interactions with biological systems.
A smaller fragment isn’t necessarily more effective.
Similarly, increasing the concentration doesn’t guarantee improved penetration.
For professional formulators, molecular weight should be considered alongside the raw material’s identity, proposed mechanism, stability, and supporting evidence.
Understanding PDRN Delivery Systems
Researchers have explored several approaches to improving the delivery of nucleic acid-based materials.
These include lipid-based carriers, encapsulation systems, and other specialised formulation technologies.
Such approaches may influence stability, distribution, and delivery depending on the material and system used.
However, the term encapsulated PDRN shouldn’t automatically be treated as proof of successful skin penetration.
A delivery system still needs to demonstrate appropriate stability, release behaviour, and relevant performance.
And if a supplier claims improved penetration, it’s reasonable to ask what testing supports that claim.
- Was penetration measured using a reconstructed skin model, excised human or animal skin, or human volunteers?
- Was the intact ingredient identified, or was the measurement based on a marker that could also represent breakdown products?
These details matter when interpreting scientific evidence.
What Cosmetic Formulators Need to Know Before Using PDRN
Let’s imagine you’ve decided to investigate PDRN for a facial serum.
You find a supplier offering a water-soluble PDRN ingredient with an attractive technical description.
It’s tempting to add it to a formulation and begin testing.
But before doing that, there are several questions worth answering.
Understanding the Actual Raw Material You’re Purchasing
The first step is establishing precisely what the supplier is providing.
Is it purified PDRN, a sodium salt of DNA, hydrolysed DNA, or a commercial blend containing a DNA-derived material?
Different suppliers may use the term PDRN for materials with different molecular characteristics.
The exact INCI declaration also depends on the supplied ingredient.
You may encounter names such as Sodium DNA or Hydrolyzed DNA, but these names should not automatically be treated as proof that two raw materials are chemically or functionally equivalent.
Request the supplier’s complete INCI composition, technical data sheet, and relevant specifications.
Understanding Molecular Weight and Purity
For a nucleic acid-based ingredient, the molecular weight distribution is an especially important characteristic.
You’ll also want to understand how the material was extracted, processed, and purified.
Relevant quality information may include DNA content, molecular size distribution, microbial quality, residual impurities, and batch-to-batch consistency.
For fish-derived materials, the supplier should also provide appropriate information about source identity, purification, and relevant residual proteins or other impurities.
A statement such as “99% pure PDRN” isn’t particularly informative unless the supplier explains how purity was defined and measured.
Understanding the Difference Between PDRN Solution and Active Content
Here’s another area where beginners can become confused.
Suppose you purchase a commercial solution containing 0.5% of a defined PDRN material.
You decide to incorporate that supplied solution at 2% in your formulation.
The final concentration of the defined material would be:
2% × 0.5% ÷ 100 = 0.01%
That equals 100 ppm.
This example is for calculation purposes only and isn’t a recommended formulation concentration.
It demonstrates why you need to distinguish between the percentage of a commercial raw material and the actual concentration of the DNA-derived component.
The ingredient name on the front of a serum doesn’t necessarily tell you how much active material is present.
Formulation Stability and Compatibility Challenges
PDRN isn’t simply another botanical extract or conventional moisturising ingredient.
It’s a DNA-derived material, and its chemical and physical properties deserve appropriate attention.
Evaluating pH and Chemical Stability
Nucleic acid-based materials can undergo degradation under certain environmental conditions.
Factors such as pH, temperature, and processing conditions may influence the stability of a particular preparation.
However, different PDRN materials may have different stability profiles depending on molecular structure, purification, and supplied formulation.
There is no single universal pH recommendation that can safely be applied to every ingredient marketed as PDRN.
Before incorporating the material into a cosmetic product, review the supplier’s recommended pH range and relevant stability information.
Heat Sensitivity and Manufacturing Conditions
Another common assumption is that every PDRN ingredient must be added during the cool-down phase.
That may be appropriate for some commercial materials, but it shouldn’t be treated as a universal rule.
The correct incorporation method depends on the stability and processing requirements of the specific raw material.
Where suitable, lower-temperature processing may help limit unnecessary exposure to heat.
However, the manufacturing method should be selected using relevant technical information rather than generic assumptions.
Compatibility With Other Cosmetic Ingredients
You may want to combine PDRN with familiar skincare materials such as hyaluronic acid, glycerin, niacinamide, peptides, or other active ingredients.
But compatibility needs to be evaluated within the complete formulation.
Potential considerations include pH, ionic interactions, ingredient solubility, preservation, and the stability of the nucleic acid material.
For example, the negatively charged nature of many DNA-derived materials may be relevant when investigating interactions with certain cationic ingredients or polymers.
That doesn’t mean every such combination is incompatible.
It means the interaction should be assessed rather than assumed.
Likewise, claims that PDRN must never be combined with vitamin C or exfoliating acids are too broad without identifying the actual ingredients and formulation conditions.
Preservation and Product Stability Cannot Be Overlooked
Suppose you’ve developed a PDRN facial serum.
It looks beautiful, has a pleasant texture, and remains visually unchanged after several weeks.
Does that mean your formulation is successful?
Not necessarily.
A PDRN serum still needs to meet the same fundamental safety and stability expectations as other comparable cosmetic products.
Microbiological Protection Matters
Water-containing cosmetic formulations generally require an appropriate preservation strategy.
The presence of PDRN doesn’t replace this requirement.
The preservation system should be suitable for the complete formulation and evaluated using appropriate methods.
This is particularly important when developing products intended for commercial distribution.
Testing the Stability of the PDRN Itself
Traditional cosmetic stability testing often includes observations of appearance, odour, colour, viscosity, pH, and physical separation.
These measurements remain useful.
However, they don’t necessarily establish whether the PDRN remains chemically intact.
Where scientifically justified, a formulator may need suitable analytical methods to examine DNA content, fragment size distribution, or degradation.
Depending on the material and analytical objective, this could involve appropriate chromatographic or molecular characterisation techniques.
The exact method needs to be validated for the intended purpose.
That’s why ingredient-specific stability can be an important consideration when working with advanced cosmetic actives.
Fish-Derived PDRN vs Plant-Derived PDRN
With growing interest in vegan skincare, several brands have introduced alternatives marketed as plant-based PDRN.
These ingredients may appeal to consumers who prefer to avoid animal-derived materials.
But from a formulation perspective, the source is only one part of the decision.
Are Plant-Derived PDRN Ingredients the Same as Salmon PDRN?
Not necessarily.
DNA-derived materials can differ in molecular weight distribution, sequence composition, processing, impurities, and other physicochemical characteristics.
Even if two materials are both marketed as PDRN, they may not have identical properties.
The evidence supporting one source also doesn’t automatically establish the performance of another.
The 2025 research on low-molecular-weight peony-derived PDRN is interesting, but it shouldn’t be treated as proof that every botanical DNA extract has the same biological activity.
Understanding Vegan and Natural Claims
If a raw material is marketed as vegan PDRN, request documentation explaining its source and manufacturing process.
A plant-derived origin may support certain sourcing claims, but claims about vegan status, natural origin, or organic certification need their own supporting documentation.
An INCI name alone doesn’t establish these characteristics.
For professional cosmetic formulation, traceability and supplier transparency are essential.
Is PDRN Safe for Cosmetic Use?
Another important question is whether PDRN is safe when incorporated into skincare products.
Some clinical investigations of nucleotide-based treatments have reported favourable short-term tolerability.
However, the available evidence remains limited by the relatively small number of participants, differences between preparations, and limited long-term follow-up.
Safety also needs to be considered separately for different routes of administration.
Fish-Derived Materials and Allergy Considerations
Traditional PDRN is often derived from fish sources.
Although these ingredients undergo purification, formulators should not automatically assume that every commercial preparation has the same residual impurity profile.
Where relevant, ask suppliers for information about residual proteins, source-related impurities, and suitable safety assessments.
For consumers with known fish allergies, the available information should be considered carefully rather than assuming that all fish-derived PDRN products are either universally safe or universally unsafe.
Cosmetic Use Is Different From Injectable Use
Another important distinction is that raw materials intended for topical cosmetic use are not automatically suitable for injection or other procedures that bypass the skin barrier.
Injectable products require different standards of manufacturing, quality control, sterility, safety assessment, and regulatory oversight.
A cosmetic serum should never be treated as an injectable preparation simply because it contains the same general category of ingredient.
Formulators should also avoid encouraging consumers to use ordinary cosmetic products with microneedling devices unless the product and procedure have been specifically evaluated for that purpose.
Making Responsible Claims About PDRN Skincare Products
One of the biggest challenges with trending ingredients is the gap between scientific research and marketing language.
You’ve probably seen PDRN products described as repairing DNA, regenerating skin, stimulating collagen, reversing ageing, or producing injectable-like results.
These statements can sound impressive.
But they require careful evaluation.
Ingredient Evidence Isn’t Automatically Product Evidence
Imagine a supplier provides a study showing that a particular PDRN preparation influences fibroblast activity in a laboratory.
You incorporate that material into your moisturiser.
Can you now claim that your finished moisturiser clinically increases collagen production?
Not simply on the basis of that study.
The ingredient may behave differently in the finished formulation.
Its concentration, stability, delivery, and interactions with the other ingredients can influence performance.
The finished product’s claims need appropriate evidence relevant to the actual formulation and intended use.
Understanding the Regulatory Implications
Cosmetic claims are regulated differently across markets.
For example, European cosmetic claims must satisfy requirements relating to truthfulness, evidential support, and honesty.
In the United States, claims that a product treats disease or affects the structure or function of the body may result in the product being regulated as a drug rather than solely as a cosmetic.
For a PDRN skincare product, appearance-focused claims, such as helping skin look smoother or improving the appearance of dryness, may be more appropriate cosmetic directions when supported by suitable evidence.
Claims involving wound healing, tissue regeneration, or directly increasing collagen production require particular regulatory attention.
The important principle is simple.
Should Cosmetic Formulators Be Using PDRN?
After looking at the science, you might be wondering whether PDRN is worth investigating in skincare formulations.
It certainly has scientific interest.
Research involving nucleotide-based materials has reported promising findings in medical, aesthetic, and laboratory settings.
And recent topical studies suggest that some carefully selected or engineered PDRN preparations may provide measurable cosmetic benefits.
However, the current evidence is not strong enough to assume that all PDRN ingredients are effective in every topical formulation.
The specific material, delivery system, concentration, product composition, stability, and supporting clinical evidence all matter.
For a professional formulator, this means PDRN should be evaluated as an individual raw material with its own technical requirements.
It shouldn’t be added simply because the ingredient is trending.
You also need to consider whether the intended product benefits could be achieved using other ingredients with stronger supporting evidence.
For example, well-designed moisturising formulations containing appropriate humectants, emollients, and barrier-supporting ingredients may already provide meaningful improvements in skin hydration and appearance.
A newer active ingredient should contribute a justified benefit rather than unnecessary complexity.
Learning to Evaluate Trending Ingredients With Learn Canyon
PDRN provides a useful example of why professional cosmetic formulation requires more than simply knowing which ingredients are popular.
Understanding the ingredient’s name is only the beginning.
You also need to examine its molecular characteristics, supplied concentration, proposed mechanism, stability, compatibility, delivery, and supporting evidence.
At Learn Canyon, we believe cosmetic formulation education should help learners develop the ability to critically evaluate raw materials and scientific information.
Our professional formulation courses focus on ingredient knowledge, cosmetic chemistry, formulation principles, practical manufacturing understanding, and the technical considerations involved in cosmetic product development.
Because a skilled formulator doesn’t simply ask whether an ingredient is trending.
They ask whether it’s suitable for the product, whether it can be incorporated responsibly, and whether the available evidence supports its intended use.
Common Questions About PDRN in Skincare
What is PDRN in skincare?
PDRN stands for Polydeoxyribonucleotide. It’s a material composed of fragments of DNA. Traditionally, PDRN has been produced using DNA extracted from the sperm cells of certain fish species, including rainbow trout and chum salmon, which is why it’s frequently described as salmon DNA in skincare marketing. Commercial PDRN ingredients are processed and purified raw materials.
Does topical PDRN actually work?
Some specifically studied topical PDRN formulations may have measurable effects, but that doesn’t mean every PDRN serum on the market has the same level of evidence. The specific material, delivery system, concentration, product composition, stability, and supporting clinical evidence all matter.
Why is skin penetration a challenge for PDRN?
Traditional PDRN preparations contain relatively large DNA fragments that are also highly hydrophilic and negatively charged. Together, these characteristics can make passive penetration through the stratum corneum challenging.
Can a PDRN skincare product claim to repair DNA or boost collagen?
Not simply on the basis of ingredient studies. The finished product’s claims need appropriate evidence relevant to the actual formulation and intended use. Claims involving wound healing, tissue regeneration, or directly increasing collagen production require particular regulatory attention.
Final Thoughts: PDRN Is Promising, but the Evidence Still Matters
PDRN is an interesting ingredient category with a growing body of scientific research.
Its investigation in tissue repair and aesthetic medicine has encouraged researchers to explore its potential in topical skincare.
And more recent studies suggest that certain PDRN preparations may have meaningful cosmetic applications.
But we need to be careful about how these findings are interpreted.
Evidence from injectable treatments doesn’t automatically establish effectiveness in facial creams.
A study involving a specifically modified PDRN material doesn’t prove that every commercially available PDRN ingredient behaves identically.
And a supplier’s laboratory results don’t automatically validate the finished product.
For cosmetic formulators, the lesson goes beyond PDRN itself.
Trending ingredients will always come and go.
Some will develop strong scientific support. Others may remain more compelling in marketing than in clinical research.
Your role as a formulator is to understand the difference.
Because professional cosmetic formulation isn’t about creating products with the most fashionable ingredients.
It’s about developing products through informed ingredient selection, scientifically justified formulation decisions, and appropriate testing.
And that’s a much stronger foundation for creating skincare products that consumers can trust.
Ready to Deepen Your Cosmetic Formulation Knowledge?
If you’re passionate about cosmetic chemistry, advanced skincare ingredients, and professional formulation science, explore the educational programmes available at Learn Canyon.
Explore Professional Cosmetic Formulation Courses at Learn Canyon
Develop the knowledge to critically evaluate cosmetic ingredients, understand formulation challenges, and make better-informed product development decisions.
Keep learning: Related reading: How to Develop a Beauty Product That Customers Actually Want to Buy · Must-Know Skills for Beginner Cosmetic Formulators. Want to learn this properly? Explore our Free 4-Day Beginner Formulator Experience.
